ANDE compared with COLL: revenue, margins and what each company keeps, and the suppliers and customers both name

ANDEAndersons, Inc.

Mkt capRevenueRevenue

COLLCollegium Pharmaceutical, Inc

Mkt capRevenueRevenue

Compare

ANDEAndersons, Inc.

COLLCollegium Pharmaceutical, Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

COLL: latest quarter is a loss; flow not drawable.Method ›

Price

rebased to 0%

ANDE, solidCOLL, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ANDE 0

None

Shared 0

No disclosed counterparties: ANDE.

Only COLL 2

—Hikma Pharmaceuticals USAunlistedsupplier

—Grünenthalunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

ANDEAndersons, Inc.

64.07▲+2.56%· post 64.07

Mkt cap$2.2BRevenue$3.1BQ2 FY26Revenue$11.0BFY25

COLLCollegium Pharmaceutical, Inc

23.77▼−1.06%· post 23.78

ClosedOct 30 '26

Mkt cap$774.8MRevenue$200MQ2 FY26Revenue$781MFY25

Compare

ClosedOct 30 '26

ANDEAndersons, Inc.

COLLCollegium Pharmaceutical, Inc

64.07▲+2.56%post 64.07

Price

23.77▼−1.06%post 23.78

$2.2B

Mkt cap

$774.8M

Q2 FY26$3.1B

Revenue

$200MQ2 FY26

FY25$11.0B

Revenue

$781MFY25

ANDE64.07▲+2.56%vsCOLL23.77▼−1.06%ClosedOct 30 '26